CERENOME, INC. filed a Form D with the Securities and Exchange Commission on 2026-09-18.
CERENOME, INC. filed a Form D notice of an exempt securities offering with the SEC on September 18, 2026. CERENOME, INC. trades on Nasdaq as CNSY; it was formerly Plus Therapeutics, Inc. The filing reports $3M sold. Its industry group is Other Health Care. It names Marc Hedrick (President and Chief Executive Officer), Andrew Sims (Chief Financial Officer), Howard Clowes (Director) (SEC Form D, September 18, 2026).
In its own words: “Cerenome is building an integrated CNS oncology platform connecting diagnostics, therapeutics, and clinical data into one system.” (cerenome.com, checked November 1, 2026)
CERENOME, INC. raised on Sep 18. 125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Cerenome, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like CERENOME, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns CERENOME, INC.
Free to see. No signup.
More on the people and the money behind CERENOME, INC., from the filings we hold.
Other Health Care raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when CERENOME, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when CERENOME, INC. raises, hires or launches. No email unless you switch it on.
Watch CERENOME, INC. →Get the full cited report on CERENOME, INC.
What the filing shows about CERENOME, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on CERENOME, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives CERENOME, INC.'s address as 6420 Levit Green Boulevard, Suite 310, Houston, TX 77021.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
CERENOME, INC. is a registered filer with the SEC (CIK 1095981) and has filed since 2026-09-18. 1 filing is on record, the latest on 2026-09-18.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
CERENOME, INC.'s Form D of 2026-09-18 names Marc Hedrick, Andrew Sims, Howard Clowes and 4 more as its officers, directors or promoters.
Its new offerings report $3M sold across 1 offering, as its own filings state.
Trailing twelve months. 868 filings in Other Health Care, totalled by week. The dot is this raise, $3M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
The Investor Relations website contains information about Cerenome, Inc.'s business for stockholders, potential investors, and financial analysts.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Marc Hedrick is named as President and Chief Executive Officer on the Form D that CERENOME, INC. filed with the SEC on 18 September 2026, one of 7 people that filing names.
On the filing as: Executive Officer.
Andrew Sims is named as Chief Financial Officer on the Form D that CERENOME, INC. filed with the SEC on 18 September 2026, one of 7 people that filing names.
Howard Clowes is named as Director on the Form D that CERENOME, INC. filed with the SEC on 18 September 2026, one of 7 people that filing names.
An van Es-Johansson is named as Director on the Form D that CERENOME, INC. filed with the SEC on 18 September 2026, one of 7 people that filing names.
On the filing as: Director.
Richard Hawkins is named as Chairman of the Board on the Form D that CERENOME, INC. filed with the SEC on 18 September 2026, one of 7 people that filing names.
Ronald Andrews is named as Director on the Form D that CERENOME, INC. filed with the SEC on 18 September 2026, one of 7 people that filing names.
Kyle Guse is named as Director on the Form D that CERENOME, INC. filed with the SEC on 18 September 2026, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2026-09-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about CERENOME, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on CERENOME, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CERENOME, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist CERENOME, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind CERENOME, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-27 (plustherapeutics.gcs-web.com).
Each opens in a new tab, filled in for CERENOME, INC.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises, week of 2026-09-14 · Health care raises in Houston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/cerenome-inc-form-d-395734